Considering the elevated GLP‐1 levels in starving individuals with sarcopenia (Figure 1), we investigated the potential impact of consistent GLP‐1 treatment on myoblasts and its role in regulating myogenic differentiation. The gene discussed is GLP1R; the disease is sarcopenia.